CNS Drugs Journal Issues Research Articles in March 2023 Edition
March 19, 2023
March 19, 2023
CHAM, Switzerland, March 19 -- CNS Drugs, a journal that says it provides researchers and healthcare professionals with information on the aspects of drug therapies used for the management of neurological and psychiatric disorders, published research articles on the following topics in its March 2023 edition:
Review Articles:
* Immunoregulatory and/or Anti-inflammatory Agents for the Management of Core and Associated Symptoms in Individuals with Autism Spectrum Disorde . . .
Review Articles:
* Immunoregulatory and/or Anti-inflammatory Agents for the Management of Core and Associated Symptoms in Individuals with Autism Spectrum Disorde . . .